期刊文献+

高、低表达三磷酸腺苷结合转运蛋白G超家族成员2的人鼻咽癌耐药细胞生物学特性差异研究 被引量:6

Different biological characteristics of high-and low-expression of ATP-binding cassette transporter in drug resistant human nasopharyngeal carcinoma cell
下载PDF
导出
摘要 目的探讨高表达与低表达三磷酸腺苷(ATP)结合转运蛋白G超家族成员2(ABCG2)的人多药耐药鼻咽癌CNE2/DDP细胞(简写作ABCG2High细胞、ABCG2Low细胞)的生物学差异,分析两种细胞的耐药特点。方法分离ABCG2High和ABCG2Low细胞,检测其体外克隆形成率并分析细胞周期。流式细胞术(FCM)检测两种细胞传代前及传至第5代时ABCG2阳性表达率的差异。RT-PCR检测耐药基因ABCG2、Bcl-2、MDR1、MRP、MGMT的mRNA表达差异。MTT法检测两种细胞在1~14d的吸光度,绘制生长曲线;检测两种细胞对氟尿嘧啶、顺铂、长春新碱、卡铂、表阿霉素、柔红霉素、紫杉醇、丝裂霉素等化疗药物耐药性的差异。结果ABCG2High和ABCG2Low细胞在7d内的克隆形成率分别为25.24%±1.18%和16.28%±1.11%。FCM分析显示,ABCG2High的S期细胞占41.5%,ABCG2Low的G1/M0期细胞占63.9%。FCM分离后,ABCG2的表达率在ABCG2High细胞为98%,在ABCG2Low细胞为2%;两种细胞传至第5代,ABCG2在前者的表达率降低为75%,在后者升高至20%。RT-PCR显示,ABCG2mRNA在ABCG2High细胞中的表达明显高于ABCG2Low细胞,其他耐药基因在两种细胞中的表达无差异。生长曲线显示,ABCG2High细胞早期生长速度较ABCG2Low细胞快,后期生长速度逐渐减慢。耐药谱分析表明,ABCG2High细胞对8种抗肿瘤药物的IC50值高于ABCG2Low细胞两倍以上,两者差异有统计学意义(P<0.05)。结论ABCG2High细胞是一种快周期细胞,而ABCG2Low细胞为慢周期细胞,前者更具有多药耐药的特点,可用于ABCG2介导的鼻咽癌细胞非经典多药耐药的研究。 Objective To investigate the different biological characteristics of high-and low-expression of ATP-binding cassette transporter(ABCG2)in human multi-drug resistant nasopharyngeal carcinoma CNE2/DDP cell line(abbreviated as ABCG2High cell and ABCG2Low cell),and to analyze drug-resistant characteristics of the two cell lines.Methods ABCG2High and ABCG2Low cells were isolated by flow cytometry,while their cloning efficiency,cell cycle distribution,and the expression of ABCG2 before and after the 5th passage were examined as well.mRNA expressions of drug-resistant genes,such as ABCG2,Bcl-2,MDR1,MRP and MGMT,were detected by reversed transcriptive polymerase chain reaction(RT-PCR).MTT assay was utilized to detect the light absorbance(A)from day 1 to 14 to determine growth kinetics.Moreover,the drug sensitivity of the two cell lines to fluorouracil,cisplatin,vincristine,carboplatin,epirubicin,daunorubicin,paclitaxel and mitomycin were detected by MTT assay.Results The cloning efficiency of ABCG2High and ABCG2Low cells was 25.24%±1.18% and 16.28%±1.11%,respectively,on day 7.ABCG2High cells in S phase accounted for 41.5%,while the ABCG2Low cells in the G1/M0 phase went up to as high as 63.9%.The expression of ABCG2 in original ABCG2HighCNE2/DDP cells was 98%,while in ABCG2Low CNE2/DDP cells was 2%.However,at the 5th passage,the expression of ABCG2 decreased to 75% in the former cells and increased to 20% in the latter ones.The expression of ABCG2 mRNA in ABCG2High cells was obviously higher than that in ABCG2Low cells,while there was no difference in expression of other drug resistance genes between two cell lines.The growth velocity of ABCG2High cells exceeded that of ABCG2Low cells in early stage,but it slowed down 7 days later.MTT assay showed that IC50 of ABCG2High cells to 8 kinds of anti-tumor drugs were twofold higher than that of ABCG2Low cells,with statistically significant difference between them(P〈0.05).Conclusions ABCG2High cell is a kind of fast cycle cell,on the contrary,ABCG2Low ce
出处 《解放军医学杂志》 CAS CSCD 北大核心 2008年第8期987-991,共5页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助项目(30471663)
关键词 三磷酸腺苷结合转运蛋白G超家族成员2 基因 MDR 鼻咽肿瘤 ATP-binding cassettes transporter(ABCG2) genes,MDR nasopharyngeal neoplasms
  • 相关文献

参考文献11

  • 1Dean M, Fojo T, Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer, 2005, 5(4): 275. 被引量:1
  • 2Dolmenberg VS, Donnenberg AD. Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J Clin Pharmacol, 2005,45 (8) : 872. 被引量:1
  • 3姜润德,张立新,岳文,朱运峰,路浩军,刘昕,岑信棠,关新元,李春海.人鼻咽癌顺铂耐药细胞系(CNE2/DDP)的建立及耐药相关基因的筛选[J].癌症,2003,22(4):337-345. 被引量:37
  • 4Robert W, Robey, Orsolya Polgar, et al. ABCG2:determining its relevance in clinical drug resistance. Cancer Metastasis Rev, 2007,26 (1):39. 被引量:1
  • 5Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors Blood, 2002,99(2) : 507. 被引量:1
  • 6Zhou S, Morris JJ, Barnes Y, et al. Bcrpl gene expression is required fornormal numbers of side population stem cells in mice, and oonfers relative protection to mitoxantrone in hematopoietic ceils in vivo. Proc Nat Acad of Sci USA, 2002, 99(12):339. 被引量:1
  • 7Minor DR, Monroe D, Damieo LA, et al. A phase II study of thalidevara in advanced metastatic renal cell carcinoma. Invest New Drugs, 2002,20(4) :389. 被引量:1
  • 8Montanaro F, Liadaki K, Schienda J, et al. Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp Cell Res, 2004, 298(1):144. 被引量:1
  • 9Doyle LA, Ross DD. Multidrug resistance medicated by the breast cancer resistance protein BCRP(ABCG2). Oncogene, 2003, 22(47): 7340. 被引量:1
  • 10Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas AB-CG2^ + and ABCG2- cancer cells are similarly tumorigenic. Cancer Res, 2005,65(14): 6207. 被引量:1

二级参考文献25

  • 1李曦 郭先健 黄桂君 等.人肺腺癌多药抗药细胞系 LC- 3/CDDP的建立及耐药机制 [J].中国肿瘤临床,1997,10(2):93-95. 被引量:1
  • 2Gao Z,Fields JZ,Boman BM.Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells.Anticancer Res,1998,18(4C): 3073 被引量:1
  • 3Roth JA,Grammer SF.Gene replacement therapy for non-small cell lung cancer: a review.Hematol Oncol Clin North Am,2004,18(1):215 被引量:1
  • 4Ramalingam S,Belani CP.Results of clinical trials for locally advanced and metastatic nonsmall-cell lung cancer.Semin Thorac Cardiovasc Surg,2003,15(4):438 被引量:1
  • 5Riedel RF,Crawford J.Small-cell lung cancer: a review of clinical trials.Semin Thorac Cardiovasc Surg,2003,15(4):448 被引量:1
  • 6Mattern J,Koomagi R,Volm M.Expression of drug resistance gene products during progression of lung carcinomas.Oncol Rep,2002,9(6): 1181 被引量:1
  • 7Monzo M,Rosell R,Taron M.Drug resistance in non-small cell lung cancer.Lung Cancer,2001,34(Suppl 2): S91 被引量:1
  • 8Reeve JG,Rabbitts PH,Twentyman PR.Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69.Br J Cancer,1989,60(3): 339 被引量:1
  • 9Solan MJ,Werner WM.Prognostic factors in non-small cell lung cancer.Semin Surg Oncol,2003,21(2): 64 被引量:1
  • 10Cole SP,Bhardwj G,Gerlach JH et al.Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line.Science,1992,258(5088): 1650 被引量:1

共引文献40

同被引文献77

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部